ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
192 hedge funds and large institutions have $1.28B invested in Intercept Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 70 increasing their positions, 52 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
20% less capital invested
Capital invested by funds: $1.6B → $1.28B (-$320M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
192
Holding in Top 10
2
Calls
$72.5M
Puts
$81.2M
Top Buyers
| 1 | +$26.4M | |
| 2 | +$12.6M | |
| 3 | +$12.5M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$12.1M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$9.43M |
Top Sellers
| 1 | -$14.2M | |
| 2 | -$11M | |
| 3 | -$10.3M | |
| 4 |
Millennium Management
New York
|
-$8.92M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.15M |